Importantly, from the therapeutic potential point of view, the three FGFRs that we could show to be differentially expressed between benign and malignant adrenocortical tumors, FGFR1, 2 and 4, were also confirmed in the larger cohort of FFPE tissues. Here, FGFR1 is linked to adrenal cortex neoplasm.